Life Science Company News

Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing

Read more ››
By: GlobenewsWire - 22 Jun 2022

Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

Read more ››
By: GlobenewsWire - 22 Jun 2022

BioCryst Announces ORLADEYO® (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2022

Read more ››
By: GlobenewsWire - 22 Jun 2022

TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium

Read more ››
By: GlobenewsWire - 22 Jun 2022

Tonix Pharmaceuticals Announces Pricing of $30 Million Private Placement of Convertible Redeemable Preferred Stock

Read more ››
By: GlobenewsWire - 22 Jun 2022

Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment of Patients with Dystrophic Epidermolysis Bullosa

Read more ››
By: GlobenewsWire - 22 Jun 2022

ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application

Read more ››
By: GlobenewsWire - 22 Jun 2022

ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares

Read more ››
By: GlobenewsWire - 22 Jun 2022

Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights

Read more ››
By: GlobenewsWire - 22 Jun 2022

Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors

Read more ››
By: GlobenewsWire - 22 Jun 2022

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 22 Jun 2022

BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)

Read more ››
By: GlobenewsWire - 22 Jun 2022

BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease

Read more ››
By: GlobenewsWire - 22 Jun 2022

Plus Therapeutics and Biocept Announce Comprehensive Laboratory Services Agreement for the ReSPECT-LM Trial

Read more ››
By: GlobenewsWire - 22 Jun 2022

Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin

Read more ››
By: GlobenewsWire - 22 Jun 2022

OpGen Announces 1,000th Patient Sample Enrolled in Clinical Trial for Unyvero Urinary Tract Infection Panel

Read more ››
By: GlobenewsWire - 22 Jun 2022

Arch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling Channel

Read more ››
By: GlobenewsWire - 22 Jun 2022

BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic

Read more ››
By: GlobenewsWire - 22 Jun 2022

CymaBay Therapeutics Presents Positive PBC Data at the International Liver Congress™ 2022

Read more ››
By: GlobenewsWire - 22 Jun 2022

Innovative Medical Robotics Company, Clarapath, Passes First Round of Certifications; Expands Global Headquarters

Read more ››
By: GlobenewsWire - 22 Jun 2022
Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Enhance your business development with Biotechgate